13 julio 2021

FDC Launches Favipiravir Oral Suspension .

 FDC Launched India's First Oral Suspension of Favipiravir - Favenza Oral Suspension, Used To Treat Mild To Moderate Cases of COVID19 .

This prescription-only solution is currently available at all retail medical outlets and hospital pharmacies across the country.

The Favenza suspension is unique due to its Convenient Loading Dose (Day 1) of 18 ml in the morning and 18 ml in the evening. The results of which are equivalent to 9 tablets of Favipiravir 400mg making the process of Covid-19 treatment hassle free. ...